Long‐term efficacy and safety of eslicarbazepine acetate: results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy
P Halász, JA Cramer, D Hodoba, A Członkowska… - …, 2010 - Wiley Online Library
Purpose: To evaluate the long‐term efficacy and safety of once daily eslicarbazepine
acetate (ESL) as adjunctive therapy for partial‐onset seizures in adults with epilepsy …
acetate (ESL) as adjunctive therapy for partial‐onset seizures in adults with epilepsy …
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
P Halász, JA Cramer, D Hodoba, A Członkowska… - Epilepsia, 2010 - europepmc.org
Purpose To evaluate the long-term efficacy and safety of once daily eslicarbazepine acetate
(ESL) as adjunctive therapy for partial-onset seizures in adults with epilepsy. Methods One …
(ESL) as adjunctive therapy for partial-onset seizures in adults with epilepsy. Methods One …
Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy
P Halász, JA Cramer, D Hodoba, A Członkowska… - Epilepsia, 2010 - infona.pl
Purpose: To evaluate the long‐term efficacy and safety of once daily eslicarbazepine
acetate (ESL) as adjunctive therapy for partial‐onset seizures in adults with epilepsy …
acetate (ESL) as adjunctive therapy for partial‐onset seizures in adults with epilepsy …
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
P Halász, JA Cramer, D Hodoba, A Członkowska… - 2010 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the long-term efficacy and safety of once daily eslicarbazepine acetate
(ESL) as adjunctive therapy for partial-onset seizures in adults with epilepsy. Methods One …
(ESL) as adjunctive therapy for partial-onset seizures in adults with epilepsy. Methods One …
[引用][C] Long-term efficacy and safety of eslicarbazepine acetate: Results of a I-year open-label extension study in partial-onset seizures in adults with epilepsy
P HALASZ, JA CRAMER, D HODOBA… - Epilepsia …, 2010 - pascal-francis.inist.fr
Long-term efficacy and safety of eslicarbazepine acetate: Results of a I-year open-label extension
study in partial-onset seizures in adults with epilepsy CNRS Inist Pascal-Francis CNRS Pascal and …
study in partial-onset seizures in adults with epilepsy CNRS Inist Pascal-Francis CNRS Pascal and …
[引用][C] Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
P Halász, JA Cramer, D Hodoba, A Czåonkowska… - Epilepsia, 2010 - elibrary.ru
Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
P Halász, JA Cramer, D Hodoba… - Epilepsia …, 2010 - search.ebscohost.com
To evaluate the long-term efficacy and safety of once daily eslicarbazepine acetate (ESL) as
adjunctive therapy for partial-onset seizures in adults with epilepsy. One-year open-label …
adjunctive therapy for partial-onset seizures in adults with epilepsy. One-year open-label …